Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Shuyun Ma"'
Publikováno v:
Translational Oncology, Vol 51, Iss , Pp 102184- (2025)
Objectives: To evaluate the efficacy and the incidence of symptomatic radiation pneumonitis (RP) of the adaptive radiation strategy with V20 limitation in stage III non-small cell lung cancer (NSCLC) patients receiving concurrent immunotherapy and ra
Externí odkaz:
https://doaj.org/article/48c540ddc9ab4ac5ae48da6f40f93290
Publikováno v:
Blood Science, Vol 4, Iss 3, Pp 155-160 (2022)
Adult T-cell lymphoblastic lymphoma (T-LBL) is a rare and aggressive subtype of non-Hodgkin’s lymphoma that differs from pediatric T-LBL and has a worse prognosis. Due to its rarity, little is known about the genetic and molecular characteristics,
Externí odkaz:
https://doaj.org/article/388e9b9e831d437ca26027da9208d689
Autor:
Jun Cai, Panpan Liu, Huiqiang Huang, Yajun Li, Shuyun Ma, Hui Zhou, Xiaopeng Tian, Yuchen Zhang, Yan Gao, Yi Xia, Xuanye Zhang, Hang Yang, Lirong Li, Qingqing Cai
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-9 (2020)
Abstract Advanced natural killer/T cell lymphoma (NKTL) has demonstrated poor prognosis with currently available therapies. Here, we report the efficacy of anti-programmed death 1 (PD-1) antibody with the P-GEMOX (pegaspargase, gemcitabine, and oxali
Externí odkaz:
https://doaj.org/article/99ff2da0b38046018a5c7ce878c81a7f
Autor:
Jinni Wang, Ning Su, Yu Fang, Shuyun Ma, Yuchen Zhang, Jun Cai, Qihua Zou, Xiaopeng Tian, Yi Xia, Panpan Liu, Zhiming Li, He Huang, Huiqiang Huang, Qingqing Cai
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundPeripheral T-cell lymphoma (PTCL) is featured with a poor survival outcome. China has approved chidamide, an oral novel histone deacetylase inhibitor, for patients diagnosed with relapsed or refractory PTCL.ObjectiveWe compared the benefit
Externí odkaz:
https://doaj.org/article/4fecf38761b7440bb29208b8626da968
Publikováno v:
Journal of Contemporary Educational Research. 6:69-74
Background: In recent years, with the gradual expansion of the scale of medical education, the shortage of medical teaching resources and the reluctance of patients to cooperate with teaching have become increasingly prominent. Objective: To explore
Autor:
Huiqiang Huang, Yu Yang, Dao-Guang Chen, Yuerong Shuang, Hongmei Jing, Zhigang Peng, Han Zhang, Qingyuan Xu, Yi Xia, Jun Cai, Shenghua Xu, Bingzong Li, Qingqing Cai, Panpan Liu, Qihui Li, Shuyun Ma, Yan Gao, Yuchen Zhang, Jian-Yang Lin, Zhongjun Xia
Publikováno v:
American Journal of Hematology. 96:1481-1490
Extranodal natural killer/T-cell lymphoma, nasal-type (ENKTL) is a distinct subtype of non-Hodgkin lymphoma and most of the patients presented localized disease. Combined modality therapy (CMT), namely chemotherapy combined with radiotherapy, has bee
Publikováno v:
Histology and histopathology.
Cervical cancer (CC) is a common disease in women characterized by high recurrence rate. LncRNA ceramide synthase 6 antisense RNA 1 (CERS6-AS1) has been found to play a crucial role in the progression of breast cancer and pancreatic cancer. Neverthel
Autor:
Mei Li, Tongyu Lin, Pengfei Li, Yan Hui Liu, Shuyun Ma, Yuchen Zhang, Huiqiang Huang, Zijun Y. Xu-Monette, Fen Zhang, Liye Zhong, Le Ai, Siok Bian Ng, Soon Thye Lim, Lay Poh Khoo, Jeslin Chian Hung Ha, Sanjay de Mel, Zhongjun Xia, Ning Su, Zhi Ming Li, Choon Kiat Ong, Huilan Rao, Ken H. Young, Esther Kam Yin Wong, Qiongli Zhai, Qingqing Cai, Feng Zhu, Jun Cai, Xiao-Peng Tian, Zhihua Li, Jing Quan Lim, Runfen Cheng
Publikováno v:
Cancer Communications
Current prognostic scoring systems based on clinicopathologic variables are inadequate in predicting the survival and treatment response of extranodal natural killer/T-cell lymphoma (ENKTL) patients undergoing nonanthracyline-based treatment. We aime
Autor:
Yan Gao, Jun Cai, Yi Xia, Qingqing Cai, Shuyun Ma, Yuchen Zhang, Lirong Li, Xiaopeng Tian, Hang Yang, Panpan Liu, Yajun Li, Xuanye Zhang, Hui Zhou, Huiqiang Huang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-9 (2020)
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy
Advanced natural killer/T cell lymphoma (NKTL) has demonstrated poor prognosis with currently available therapies. Here, we report the efficacy of anti-programmed death 1 (PD-1) antibody with the P-GEMOX (pegaspargase, gemcitabine, and oxaliplatin) r
Autor:
Jun Cai, Xiaopeng Tian, Yu Fang, Qingqing Cai, Tongyu Lin, Zhongjun Xia, Mei Li, Dan Xie, Tiebang Kang, Huilan Rao, Shuyun Ma, Huiqiang Huang
Publikováno v:
Cancer Communications, Vol 40, Iss 6, Pp 245-259 (2020)
Cancer Communications
Cancer Communications
Background Adult patients with T‐cell lymphoblastic lymphoma (T‐LBL) are treated with high‐intensity chemotherapy regimens, but the response rate is still unsatisfactory because of frequent drug resistance. We aimed to investigate the potential